{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T19:12:30Z","timestamp":1791054750006,"version":"4.1.0"},"reference-count":97,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.cca.2011.10.020","type":"journal-article","created":{"date-parts":[[2011,10,20]],"date-time":"2011-10-20T22:05:07Z","timestamp":1319148307000},"page":"66-73","source":"Crossref","is-referenced-by-count":25,"title":["Mutated citrullinated vimentin antibodies in rheumatoid arthritis"],"prefix":"10.1016","volume":"413","author":[{"given":"Andrea","family":"Tesija Kuna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2011.10.020_bb0005","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0140-6736(09)60008-8","article-title":"Rheumatoid arthritis","volume":"373","author":"Klareskog","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.cca.2011.10.020_bb0010","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0140-6736(10)60826-4","article-title":"Rheumatoid arthritis","volume":"376","author":"Scott","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.cca.2011.10.020_bb0015","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1056\/NEJMra040226","article-title":"Therapeutic strategies for rheumatoid arthritis","volume":"350","author":"O'Dell","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cca.2011.10.020_bb0020","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/art.10117","article-title":"How to diagnose rheumatoid arthritis early. A prediction model for persistent (erosive) arthritis","volume":"46","author":"Visser","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cca.2011.10.020_bb0025","first-page":"301","article-title":"Rheumatoid factor","volume":"Vol I","author":"Tighe","year":"2005"},{"key":"10.1016\/j.cca.2011.10.020_bb0030","first-page":"246","article-title":"Rheumatoid factor revisited","volume":"16","author":"D\u00f6rner","year":"2004","journal-title":"Rheumatology"},{"issue":"Suppl. 2","key":"10.1016\/j.cca.2011.10.020_bb0035","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1186\/ar551","article-title":"Autoantibodies in rheumatoid arthritis and their clinical significance","volume":"4","author":"Steiner","year":"2002","journal-title":"Arthritis Res"},{"key":"10.1016\/j.cca.2011.10.020_bb0040","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1172\/JCI1316","article-title":"Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies","volume":"101","author":"Schellekens","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cca.2011.10.020_bb0045","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.cccn.2004.07.016","article-title":"Autoantibodies to citrullinated proteins in rheumatoid arthritis: clinical performance and biochemical aspects of an RA-specific marker","volume":"350","author":"Nijenhuis","year":"2004","journal-title":"Clin Chim Acta"},{"issue":"10","key":"10.1016\/j.cca.2011.10.020_bb0050","first-page":"159","article-title":"The serological diagnosis of rheumatoid arthritis. Antibodies to citrullinated antigens","volume":"106","author":"Egerer","year":"2009","journal-title":"Dtsch Arztebl Int"},{"issue":"3","key":"10.1016\/j.cca.2011.10.020_bb0055","doi-asserted-by":"crossref","first-page":"275","DOI":"10.11613\/BM.2008.025","article-title":"Antibodies to citrullinated proteins\/peptides in rheumatoid arthritis: what have we learned so far?","volume":"18","author":"Tesija-Kuna","year":"2008","journal-title":"Biochemia Medica"},{"key":"10.1016\/j.cca.2011.10.020_bb0060","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1136\/ard.2006.051391","article-title":"Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review","volume":"65","author":"Avouac","year":"2006","journal-title":"Ann Rheum Dis"},{"issue":"Suppl. 39","key":"10.1016\/j.cca.2011.10.020_bb0065","first-page":"S69","article-title":"The use of second generation anti-CCP antibody (anti-CCP2) testing in rheumatoid arthritis \u2013 a systematic review","volume":"23","author":"Riedmann","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.cca.2011.10.020_bb0070","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.autrev.2009.11.017","article-title":"Profiling of rheumatoid arthritis associated autoantibodies","author":"Conrad","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.cca.2011.10.020_bb0075","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/art.20044","article-title":"Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis","volume":"50","author":"Van Gaalen","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cca.2011.10.020_bb0080","first-page":"231","article-title":"Predictive value of antibodies to cyclic citrullinated peptide in patients with very early inflammatory arthritis","volume":"32","author":"Raza","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.cca.2011.10.020_bb0085","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1136\/ard.2004.033571","article-title":"Longitudinal analysis of citrullinated protein\/peptide antibodies (anti-CP) during 5 year follow up in early rheumatoid arthritis: anti-CP status predicts worse disease activity and greater radiological progression","volume":"64","author":"R\u00f6nnelid","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cca.2011.10.020_bb0090","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1136\/ard.2006.068247","article-title":"High anti-cyclic citrullinated peptide levels and an algorithm of four variables predict radiographic progression in patients with rheumatoid arthritis: results from a 10-year longitudinal study","volume":"67","author":"Syversen","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cca.2011.10.020_bb0095","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"Rheumatoid Arthritis Classification Criteria. An American College of Rheumatology\/European League Against Rheumatism Collaborative Initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cca.2011.10.020_bb0100","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1046\/j.1365-2249.2000.01171.x","article-title":"In the rheumatoid pannus, anti-filaggrin autoantibodies are produced by local plasma cells and constitute a higher proportion of IgG than in synovial fluid and serum","volume":"119","author":"Masson-Bessiere","year":"2000","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.cca.2011.10.020_bb0105","doi-asserted-by":"crossref","first-page":"5057","DOI":"10.4049\/jimmunol.174.8.5057","article-title":"Fibrin deimination in synovial tissue is not specific for rheumatoid arthritis but commonly occurs during synovitides","volume":"174","author":"Chapuy-Regaud","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.cca.2011.10.020_bb0110","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1093\/rheumatology\/ken092","article-title":"Sensitivity and specificity of autoantibodies binding to citrullinated carboxyterminal telopeptides of types I and II collagens in an early arthritis series","volume":"47","author":"Koivula","year":"2008","journal-title":"Rheumatology"},{"issue":"2","key":"10.1016\/j.cca.2011.10.020_bb0115","doi-asserted-by":"crossref","first-page":"R142","DOI":"10.1186\/ar1149","article-title":"Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin","volume":"6","author":"Vossenaar","year":"2004","journal-title":"Arthritis Res Ther"},{"issue":"11","key":"10.1016\/j.cca.2011.10.020_bb0120","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1093\/rheumatology\/kei023","article-title":"Citrullination of fibronectin in rheumatoid arthritis synovial tissue","volume":"44","author":"Chang","year":"2005","journal-title":"Rheumatology"},{"key":"10.1016\/j.cca.2011.10.020_bb0125","doi-asserted-by":"crossref","first-page":"R1421","DOI":"10.1186\/ar1845","article-title":"Identification of citrullinated \u03b1-enolase as a candidate autoantigen in rheumatoid arthritis","volume":"7","author":"Kinloch","year":"2005","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"10.1016\/j.cca.2011.10.020_bb0130","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/art.21629","article-title":"Deiminated Epstein-Barr virus nuclear antigen 1 is a target of anti-citrullinated protein antibodies in rheumatoid arthritis","volume":"54","author":"Pratesi","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cca.2011.10.020_bb0135","first-page":"1027","article-title":"The Sa system: A novel antigen-antibody system specific for rheumatoid arthritis","volume":"21","author":"Despres","year":"1994","journal-title":"J Rheumatol"},{"key":"10.1016\/j.cca.2011.10.020_bb0140","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1186\/ar122","article-title":"Insights into rheumatoid arthritis derived from the Sa immune system","volume":"2","author":"Menard","year":"2000","journal-title":"Arthritis Res"},{"key":"10.1016\/j.cca.2011.10.020_bb0145","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/ar1171","article-title":"Anti-Sa antibodies: prognostic and pathogenic significance to rheumatoid arthritis","volume":"6","author":"El-Gabalawy","year":"2004","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"10.1016\/j.cca.2011.10.020_bb0150","doi-asserted-by":"crossref","first-page":"R142","DOI":"10.1186\/ar1149","article-title":"Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin","volume":"6","author":"Vossenaar","year":"2004","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.cca.2011.10.020_bb0155","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/bies.10246","article-title":"Molecular architecture of intermediate filaments","volume":"25","author":"Strelkov","year":"2003","journal-title":"Bioassays"},{"key":"10.1016\/j.cca.2011.10.020_bb0160","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.berh.2006.06.005","article-title":"The role of mesenchymal cells in the pathophysiology of inflammatory arthritis","volume":"20","author":"Meyer","year":"2006","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.cca.2011.10.020_bb0165","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1002\/art.22817","article-title":"Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritis","volume":"56","author":"Bang","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cca.2011.10.020_bb0170","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1136\/ard.2003.012211","article-title":"Expression and activity of citrullinating peptidylarginine deiminase enzymes in monocytes and macrophages","volume":"63","author":"Vossenar","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cca.2011.10.020_bb0175","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1016\/j.biocel.2006.03.008","article-title":"Citrullination: A postranslational modification in health and disease","volume":"38","author":"Gy\u00f6rgy","year":"2006","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.cca.2011.10.020_bb0180","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1136\/ard.2008.103283","article-title":"Does anti-mutated citrullinated vimentin have additional value as a serologic marker in the diagnostic and prognostic investigation of patients with rheumatoid arthritis? A systematic review","volume":"69","author":"Luime","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cca.2011.10.020_bb0185","first-page":"1658","article-title":"Clinical evaluation of anti-mutated citrullinated vimentin by ELISA in rheumatoid arthritis","volume":"34","author":"Soos","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1016\/j.cca.2011.10.020_bb0190","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s12016-007-8016-3","article-title":"Antibodies to citrullinated vimentin are specific and sensitive marker for the diagnosis of rheumatoid arthritis","volume":"34","author":"Poulsom","year":"2008","journal-title":"Clin Rev Allerg Immunol"},{"key":"10.1016\/j.cca.2011.10.020_bb0195","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s00296-008-0614-8","article-title":"Value of anti-mutated citrullinated vimentin antibodies in diagnosing rheumatoid arthritis","volume":"29","author":"Sghiri","year":"2008","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.cca.2011.10.020_bb0200","doi-asserted-by":"crossref","first-page":"R142","DOI":"10.1186\/ar2570","article-title":"Antibodies to mutated citrullinated vimentin for diagnosing rheumatoid arthritis in anti-CCP-negative patients and for monitoring infliximab therapy","volume":"10","author":"Roland","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.cca.2011.10.020_bb0205","doi-asserted-by":"crossref","first-page":"314","DOI":"10.2174\/092986608783744153","article-title":"Diagnostic utility of anti-cyclic citrullinated peptide and anti-modified citrullinated vimentin antibodies in rheumatoid arthritis","volume":"15","author":"Keskin","year":"2008","journal-title":"Protein Pept Lett"},{"issue":"8","key":"10.1016\/j.cca.2011.10.020_bb0210","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1373\/clinchem.2007.087569","article-title":"Analytical and diagnostic characteristics of 11 2nd- and 3rd-generation immunoenzymatic methods for the detection of antibodies to citrullinated proteins","volume":"53","author":"Bizzaro","year":"2007","journal-title":"Clin Chem"},{"key":"10.1016\/j.cca.2011.10.020_bb0215","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1136\/ard.2009.108456","article-title":"Diagnostic value of anti-MCV antibodies in differentiating early inflammatory arthritis","volume":"69","author":"Damjanovska","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.cca.2011.10.020_bb0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3899\/jrheum.080796","article-title":"The role of anti-mutated citrullinated vimentin antibodies in the diagnosis of early rheumatoid arthritis","volume":"36","author":"Liu","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.cca.2011.10.020_bb0225","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/art.23188","article-title":"Antibodies against citrullinated vimentin in rheumatoid arthritis. Higher sensitivity and extended prognostic value concerning future radiographic progression as compared with antibodies against cyclic citrullinated peptides","volume":"58","author":"Mathsson","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cca.2011.10.020_bb0230","first-page":"1","article-title":"Antibodies against mutated citrullinated vimentin are a better predictor of disease activity at 24 months in early rheumatoid arthritis than antibodies against cyclic citrullinated peptides","volume":"35","author":"Innala","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1016\/j.cca.2011.10.020_bb0235","doi-asserted-by":"crossref","first-page":"R119","DOI":"10.1186\/ar2008","article-title":"Diagnostic value of antibodies against a modified citrullinated vimentin in rheumatoid arthritis","volume":"8","author":"Dejaco","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.cca.2011.10.020_bb0240","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/s00296-009-0854-2","article-title":"Antibody against mutated citrullinated vimentin: a new sensitive marker in the diagnosis of rheumatoid arthritis","volume":"29","author":"Wagner","year":"2009","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.cca.2011.10.020_bb0245","doi-asserted-by":"crossref","first-page":"33","DOI":"10.4137\/CMAMD.S4827","article-title":"Antibodies to mutated citrullinated vimentin in rheumatoid arthritis: Diagnostic value, association with radiological damage and axial skeleton affection","volume":"3","author":"Mansour","year":"2010","journal-title":"Clin Med Insights: Arthritis Musculoskelet Disord"},{"issue":"3","key":"10.1016\/j.cca.2011.10.020_bb0250","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1373\/clinchem.2006.078063","article-title":"Technical and diagnostic performance of 6 assays for the measurement of citrullinated protein\/peptide antibodies in the diagnosis of rheumatoid arthritis","volume":"53","author":"Coenen","year":"2007","journal-title":"Clin Chem"},{"key":"10.1016\/j.cca.2011.10.020_bb0255","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jbspin.2010.02.007","article-title":"Presence and diagnostic performances of IgA class antibodies to mutated citrullinated vimentin in rheumatoid arthritis (Letter to the Editor)","volume":"77","author":"Sghiri","year":"2010","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.cca.2011.10.020_bb0260","author":"Qin"},{"key":"10.1016\/j.cca.2011.10.020_bb0265","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/ar2903","article-title":"The use of citrullinated peptides and proteins for diagnosis of rheumatoid arthritis","volume":"12","author":"Pruijn","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.cca.2011.10.020_bb0270","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.3899\/jrheum.101086","article-title":"A comparison between IgG- and IgA-class antibodies to cyclic citrullinated peptides and to modified citrullinated vimentin in early rheumatoid arthritis and very early arthritis","volume":"38","author":"Sv\u00e4rd","year":"2011","journal-title":"J Rheumatol"},{"key":"10.1016\/j.cca.2011.10.020_bb0275","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.3899\/jrheum.081263","article-title":"The anti-mutated citrullinated vimentin response classifies patients with rheumatoid arthritis into broad and narrow responders","volume":"36","author":"Engelmann","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.cca.2011.10.020_bb0280","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1093\/rheumatology\/ken336","article-title":"IgG1 and IgG4 are the predominant subclass among auto-antibodies against two citrullinated antigen sin RA","volume":"47","author":"Engelmann","year":"2008","journal-title":"Rheumatology"},{"key":"10.1016\/j.cca.2011.10.020_bb0285","doi-asserted-by":"crossref","first-page":"R120","DOI":"10.1186\/ar3057","article-title":"Immediate determination of ACPA and rheumatoid factor \u2013 a novel point of care test for detection of anti-MCV antibodies and rheumatoid factor using a lateral-flow immunoassay","volume":"12","author":"Renger","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.cca.2011.10.020_bb0290","doi-asserted-by":"crossref","first-page":"R12","DOI":"10.1186\/ar2362","article-title":"Antibodies to mutated citrullinated vimentin and disease activity score in early arthritis: a cohort study","volume":"10","author":"Ursum","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.cca.2011.10.020_bb0295","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1136\/ard.2010.131896","article-title":"Increased cartilage turnover and circulating autoantibodies in different subsets before the clinical onset of rheumatoid arthritis","volume":"70","author":"Turesson","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cca.2011.10.020_bb0300","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1002\/art.11223","article-title":"Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis","volume":"48","author":"Rantapaa-Dahlqvist","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cca.2011.10.020_bb0305","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/art.20018","article-title":"Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors","volume":"50","author":"Nielen","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cca.2011.10.020_bb0310","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1002\/art.24716","volume":"60","author":"Van der Linden","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cca.2011.10.020_bb0315","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1136\/ard.2003.016808","article-title":"Anti-CCP antibody test predicts the disease course during 3 years in early rheumatoid arthritis (the Swedish TIRA project)","volume":"63","author":"Kastbom","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cca.2011.10.020_bb0320","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1136\/ard.2003.014233","article-title":"for the BARFOT study group. Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (anti-CCP)","volume":"63","author":"Forslind","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cca.2011.10.020_bb0325","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/qjmed\/hcm015","article-title":"Anti-CCP antibody testing as a diagnostic and prognostic tool in rheumatoid arthritis","volume":"100","author":"Niewold","year":"2007","journal-title":"Q J Med"},{"issue":"12","key":"10.1016\/j.cca.2011.10.020_bb0330","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1007\/s10067-010-1557-5","article-title":"The continuous measurement of anti-CCP-antibodies does not help to evaluate the disease activity in anti-CCP-antibody-positive patients with rheumatoid arthritis","volume":"29","author":"Landman","year":"2010","journal-title":"Clin Rheum"},{"issue":"1","key":"10.1016\/j.cca.2011.10.020_bb0335","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3899\/jrheum.100514","article-title":"Prognostic factors of radiological damage in rheumatoid arthritis: a 10-year retrospective study","volume":"38","author":"Markatseli","year":"2011","journal-title":"J Rheumatol"},{"key":"10.1016\/j.cca.2011.10.020_bb0340","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1136\/ard.2009.113092","article-title":"Prediction of radiographic progression in rheumatoid arthritis and the role of antibodies against mutated citrullinated vimentin: results from a 10-year prospective study","volume":"69","author":"Syversen","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cca.2011.10.020_bb0345","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1002\/art.20316","article-title":"Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis","volume":"50","author":"van Gaalen","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cca.2011.10.020_bb0350","doi-asserted-by":"crossref","first-page":"R303","DOI":"10.1186\/ar1187","article-title":"A combination of autoantibodies to cyclic citrullinated peptide (CCP) and HLA-DRB1 locus antigen is strongly associated with future onset of rheumatoid arthritis","volume":"6","author":"Berglin","year":"2004","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.cca.2011.10.020_bb0355","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.1002\/art.21419","article-title":"Regulation of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: contrasting effects of HLA-DR3 and the shared epitope alleles","volume":"52","author":"Irigoyen","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cca.2011.10.020_bb0360","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jaut.2005.09.005","article-title":"Redefining the HLA and RA association: To be or not to be anti-CCP positive","volume":"25","author":"de Vries","year":"2005","journal-title":"J Autoimmun"},{"key":"10.1016\/j.cca.2011.10.020_bb0365","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/ar93","article-title":"Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset","volume":"2","author":"Goldbach-Mansky","year":"2000","journal-title":"Arthritis Res"},{"key":"10.1016\/j.cca.2011.10.020_bb0370","doi-asserted-by":"crossref","first-page":"538","DOI":"10.4049\/jimmunol.171.2.538","article-title":"The conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1*0401 MHC class II molecule","volume":"171","author":"Hill","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.cca.2011.10.020_bb0375","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1086\/422827","article-title":"A missense single-nucleotide polymorphism in a gene encoding protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis","volume":"75","author":"Begovich","year":"2004","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.cca.2011.10.020_bb0380","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/rheumatology\/kel005","article-title":"The association of PTPN22 with rheumatoid arthritis and juvenile idiopathic arthritis","volume":"45","author":"Hinks","year":"2006","journal-title":"Rheumatology"},{"key":"10.1016\/j.cca.2011.10.020_bb0385","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1002\/art.21049","article-title":"Association between the PTPN22 gene and rheumatoid arthritis and juvenile idiopathic arthritis in a UK population: further support that PTPN22 is an autoimmunity gene","volume":"52","author":"Hinks","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cca.2011.10.020_bb0390","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/art.20771","article-title":"Association of a functional single-nucleotide polymorphism of PTPN22 encoding lymphoid protein phosphatase, with rheumatoid arthritis and systemic lupus erythematosus","volume":"52","author":"Orozco","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cca.2011.10.020_bb0395","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1136\/ard.60.1.67","article-title":"Use of anti-citrullinated peptide and anti-RA33 antibodies in distinguishing erosive arthritis in patients with systemic lupus erythematosus and rheumatoid arthritis","volume":"60","author":"Mediwake","year":"2001","journal-title":"Ann Rheum Dis"},{"issue":"Suppl. II","key":"10.1016\/j.cca.2011.10.020_bb0400","first-page":"648","article-title":"Anti-mutated-citrullinated vimentin antibodies (MCV) in psoriatic arthritis (Abstract","volume":"65","author":"Brickmann","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cca.2011.10.020_bb0405","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s10067-009-1345-2","article-title":"Antibodies targeting mutated citrullinated vimentin in patients with psoriatic arthritis","volume":"29","author":"Tesija-Kuna","year":"2010","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.cca.2011.10.020_bb0410","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1136\/ard.2005.040998","article-title":"Antibodies against cyclic citrullinated peptide (CCP) in psoriatic patients with or without joint inflammation","volume":"65","author":"Alenius","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cca.2011.10.020_bb0415","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s10067-006-0214-5","article-title":"Anti-CCP antibodies in rheumatoid arthritis and psoriatic arthritis","volume":"26","author":"Inanc","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.cca.2011.10.020_bb0420","first-page":"511","article-title":"Antibodies to cyclic citrullinated peptides in psoriatic arthritis","volume":"32","author":"Bogliolo","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.cca.2011.10.020_bb0425","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1136\/ard.2004.032177","article-title":"Anti-citrullinated peptide antibodies may occur in patients with psoriatic arthritis","volume":"64","author":"Cruyssen","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cca.2011.10.020_bb0430","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1136\/ard.2006.058933","article-title":"Anti-CCP2 positivity in non rheumatoid arthritis disease samples: citrulline dependent or not?","volume":"66","author":"Vannini","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.cca.2011.10.020_bb0435","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1007\/s10067-010-1544-x","article-title":"Antibodies against cyclic citrullinated peptides in infectious diseases\u2014a systematic review","volume":"29","author":"Lima","year":"2010","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.cca.2011.10.020_bb0440","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1136\/ard.61.7.608","article-title":"Prevalence and clinical significance of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis","volume":"61","author":"Avcin","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cca.2011.10.020_bb0445","first-page":"1829","article-title":"Determination of anti-cyclic citrullinated peptide antibodies in the sera of patients with juvenile idiopathic arthritis","volume":"31","author":"Low","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.cca.2011.10.020_bb0450","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1590\/S0021-75572005000800014","article-title":"The prevalence of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis","volume":"81","author":"Machado","year":"2005","journal-title":"J Pediatr (Rio J)"},{"key":"10.1016\/j.cca.2011.10.020_bb0455","first-page":"825","article-title":"Anti-cyclic citrullinated peptide (anti-CCP) antibodies in children with juvenile rheumatoid arthritis","volume":"30","author":"Van Rossum","year":"2003","journal-title":"J Rheumatol"},{"issue":"Suppl. II","key":"10.1016\/j.cca.2011.10.020_bb0460","first-page":"439","article-title":"Autoantibodies to mutated citrullinated vimentin in juvenile rheumatoid arthritis","volume":"65","author":"Hassfeld","year":"2006","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.cca.2011.10.020_bb0465","first-page":"1525","article-title":"Antibodies to mutated citrullinated vimentin and antibodies to cyclic citrullinated peptides in juvenile idiopathic arthritis","volume":"47","author":"Kuna Tesija","year":"2009","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.cca.2011.10.020_bb0470","unstructured":"Bang H, Luthke K, Gauliard A, et al. Mutated citrullinated vimentin as a candidate autoantigen for diagnosis and monitoring of disease activity in rheumatoid arthritis. Program and abstracts of EULAR 2006: 7th Annual European Congress of Rheumatology; June 21\u201324, 2006; Amsterdam, The Netherlands. Abstract THU0093."},{"key":"10.1016\/j.cca.2011.10.020_bb0475","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/ar1184","article-title":"Citrullinated proteins: sparks that may ignite the fire in rheumatoid arthritis","volume":"6","author":"Vossenaar","year":"2004","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.cca.2011.10.020_bb0480","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/ar1027","article-title":"Citrullination, a possible functional link between susceptibility genes and rheumatoid arthritis","volume":"6","author":"Vossenaar","year":"2004","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.cca.2011.10.020_bb0485","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.clim.2010.03.005","article-title":"CD161 receptor participates in both impairing NK cell cytotoxicity and the response to glycans and vimentin in patients with rheumatoid arthritis","volume":"136","author":"Richter","year":"2010","journal-title":"Clin Immunol"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000989811100581X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000989811100581X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,18]],"date-time":"2019-06-18T04:21:45Z","timestamp":1560831705000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000989811100581X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":97,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S000989811100581X"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2011.10.020","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}